Until August 31, 2026: Olink Reveal Campaign
Olink Reveal ― Midplex proteomics that accelerates clinical and drug discovery research
Campaign ongoing until orders received by August 28, 2026 (Friday).
1. 15% off when purchasing 4 Olink Reveal kits
2. 10% off for new users of Olink Reveal on 1 kit
Olink Reveal is a midplex solution that connects Explore HT (exploration) and Target (target).
It features approximately 1,000 carefully selected proteins that are important for disease research, focusing on immune and inflammation-related markers, as well as cancer, cardiovascular diseases, neurological disorders, and infectious diseases.
It includes numerous Druggable Targets directly related to clinical research and drug development, addressing a wide range of research needs from biomarker discovery to target identification and patient stratification.
It is rich in over 700 proteins with genetic evidence based on cis-pQTL data obtained from the UK Biobank Pharma Proteomics Project (UKB-PPP), strongly supporting causal inference and target validity assessment.

Inquiry about this news
Contact Us Online
Related Documents
Related catalog(4)
Olink Explore HT Brochure
Olink Reveal Brochure
Olink Target 48 Neurodegeneration Japanese Brochure
Olink Comprehensive Catalog 2026
Distributors
Testing, Analysis and Measurement
サーモフィッシャーサイエンティフィック株式会社/Thermo Fisher Scientific K.K.




